Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
572.38
-17.10 (-2.90%)
At close: Aug 25, 2025, 4:00 PM
572.25
-0.13 (-0.02%)
After-hours: Aug 25, 2025, 4:28 PM EDT
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of $59.35 billion as of August 25, 2025. Its market cap has decreased by -49.58% in one year.
Market Cap
59.35B
Enterprise Value
44.59B
1-Year Change
-49.58%
Ranking
Category
Stock Price
$572.38
Market Cap Chart
Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $59.35B, an increase of 23,451.04%. That is a compound annual growth rate of 22.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 62.48B | -20.18% |
Dec 31, 2024 | 78.28B | -18.19% |
Dec 29, 2023 | 95.69B | 21.78% |
Dec 30, 2022 | 78.57B | 15.69% |
Dec 31, 2021 | 67.92B | 31.74% |
Dec 31, 2020 | 51.55B | 25.04% |
Dec 31, 2019 | 41.23B | 1.98% |
Dec 31, 2018 | 40.43B | 0.08% |
Dec 29, 2017 | 40.39B | 4.33% |
Dec 30, 2016 | 38.72B | -31.47% |
Dec 31, 2015 | 56.49B | 35.45% |
Dec 31, 2014 | 41.71B | 52.42% |
Dec 31, 2013 | 27.36B | 65.66% |
Dec 31, 2012 | 16.52B | 221.91% |
Dec 30, 2011 | 5.13B | 89.94% |
Dec 31, 2010 | 2.70B | 38.80% |
Dec 31, 2009 | 1.95B | 33.11% |
Dec 31, 2008 | 1.46B | -8.46% |
Dec 31, 2007 | 1.60B | 38.55% |
Dec 29, 2006 | 1.15B | 29.12% |
Dec 30, 2005 | 893.00M | 73.94% |
Dec 31, 2004 | 513.40M | -36.89% |
Dec 31, 2003 | 813.50M | -0.20% |
Dec 31, 2002 | 815.10M | -33.81% |
Dec 31, 2001 | 1.23B | -5.01% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 638.90B |
Johnson & Johnson | 431.79B |
AbbVie | 372.04B |
UnitedHealth Group | 278.42B |
Novo Nordisk | 253.97B |
AstraZeneca | 251.25B |
Novartis AG | 246.51B |
Abbott Laboratories | 230.77B |